Position in JNJ
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$416,256
-$122,245 QoQ
Shares Held
1,639
-25.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#3,879
of 4,664 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Dogwood Wealth Management LLC holds $1,713,767 across 14 Drug Manufacturers - General names. JNJ ranks #2 (24.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
746 | $894,774 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,639 | $416,256 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,030 | $132,355 | |
| 4 | ABBV |
AbbVie Inc.
|
483 | $121,542 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
340 | $42,955 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
597 | $34,399 | |
| 7 | AMGN |
Amgen Inc
|
93 | $33,677 | |
| 8 | PFE |
Pfizer Inc
|
498 | $11,991 |
All Filings in JNJ
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $416,256 | 1,639 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $538,501 | 2,203 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $499,577 | 2,414 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $506,382 | 2,731 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $517,669 | 3,389 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $819,415 | 4,941 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $610,874 | 4,224 | Shares | Sole | 2025-03-04 | |
| 2024-09-30 | $601,242 | 3,710 | Shares | Sole | 2025-02-28 | |
| 2024-06-30 | $270,834 | 1,853 | Shares | Sole | 2025-03-04 | |
| 2024-03-31 | $183,658 | 1,161 | Shares | Sole | 2025-02-28 | |
| 2023-12-31 | $157,053 | 1,002 | Shares | Sole | 2025-02-28 | |
| No filing history on record for this holder in this stock. | ||||||